J C Vernant

4.3k total citations · 1 hit paper
29 papers, 3.1k citations indexed

About

J C Vernant is a scholar working on Immunology, Neurology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, J C Vernant has authored 29 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 7 papers in Neurology and 7 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in J C Vernant's work include T-cell and Retrovirus Studies (16 papers), Vector-Borne Animal Diseases (7 papers) and Animal Disease Management and Epidemiology (5 papers). J C Vernant is often cited by papers focused on T-cell and Retrovirus Studies (16 papers), Vector-Borne Animal Diseases (7 papers) and Animal Disease Management and Epidemiology (5 papers). J C Vernant collaborates with scholars based in Martinique, France and United States. J C Vernant's co-authors include Antoine Gessain, Olivier Gout, Alain Calender, Francis Barin, Guy de Thé, G Buisson, Didier Smadja, P. Cabré, H. Merle and G de-Thé and has published in prestigious journals such as The Lancet, Neurology and Clinical Infectious Diseases.

In The Last Decade

J C Vernant

28 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS

1985 2.4k citations Antoine Gessain, J C Vernant et al. The Lancet profile →

Peers

J C Vernant

IMMUN

ACS

EEBS

PFM

NEURO

Carlos A. Mora United States

Nobutaka Eiraku Japan

S Yoshimoto Japan

Norihiro Takenouchi Japan

E DeFreitas United States

Karen Yao United States

Y Nakao Japan

Mildred Foster‐Cuevas United Kingdom

K Yamaguchi Japan

Satyakam Bhagavati United States

Carlos A. Mora United States

J C Vernant

1.5k ×0.5

IMMUN

994 ×0.5

ACS

966 ×0.5

EEBS

45 ×0.2

PFM

67 ×0.3

NEURO

Citations per year, relative to J C Vernant J C Vernant (= 1×) peers Carlos A. Mora

Countries citing papers authored by J C Vernant

Since Specialization

Citations

This map shows the geographic impact of J C Vernant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J C Vernant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J C Vernant more than expected).

Fields of papers citing papers by J C Vernant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J C Vernant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J C Vernant. The network helps show where J C Vernant may publish in the future.

Co-authorship network of co-authors of J C Vernant

This figure shows the co-authorship network connecting the top 25 collaborators of J C Vernant. A scholar is included among the top collaborators of J C Vernant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J C Vernant. J C Vernant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Smadja, Didier, et al.. (2009). Clinical characteristics of HTLV-1 associated dermato-polymyositis. Acta Neurologica Scandinavica. 92(3). 206–212. 12 indexed citations

2.

Cabré, P., O. Heinzlef, H. Merle, et al.. (2001). MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 56(4). 507–514. 125 indexed citations

3.

Césaire, Raymond, et al.. (1999). Seroindeterminate patterns and seroconversions to human T‐lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion. 39(10). 1145–1149. 40 indexed citations

4.

Giraudon, Pascale, et al.. (1998). Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV‐1 infected patients with tropical spastic paraparesis. Neurology. 50(6). 1920–1920. 29 indexed citations

5.

Jallon, Pierre, et al.. (1998). [Epileptic seizures, epilepsy and risk factors. Experiences with an investigation in Martinique. Epimart Group].. PubMed. 154(5). 408–11. 3 indexed citations

6.

Vernant, J C, P. Cabré, Didier Smadja, et al.. (1997). Recurrent Optic Neuromyelitis with Endocrinopathies. Neurology. 48(1). 58–64. 101 indexed citations

7.

Smadja, Didier, et al.. (1997). Intracranial hypertension as an unusual presentation of adrenoleukodystrophy. European Journal of Neurology. 4(4). 413–415. 1 indexed citations

8.

Smadja, Didier, Marc Raynaud, Hossein Mehdaoui, et al.. (1997). [Extensive cerebral venous thrombosis resistant to heparin: local fibrinolysis with urokinase].. PubMed. 153(4). 271–4. 7 indexed citations

9.

Cabré, P., et al.. (1996). [Myocardiopathy in POEMS syndrome].. PubMed. 147(2). 124–6. 3 indexed citations

10.

Cabré, P., Didier Smadja, René‐Louis Humbel, H. Merle, & J C Vernant. (1996). Progressive encephalomyelitis with rigidity, diabetes mellitus and retinopathy: an anti‐GAD syndrome. European Journal of Neurology. 3(2). 98–101. 6 indexed citations

11.

Poser, Charles M. & J C Vernant. (1993). [Multiple sclerosis in the black population].. PubMed. 86(5 Pt 2). 428–32. 8 indexed citations

12.

Vernant, J C, R. Bellance, & G Buisson. (1991). Manifestations neurologiques associées au virus HTLV-1. La Revue de Médecine Interne. 12(6). 441–446. 3 indexed citations

13.

Bucher, B., James A. Poupard, J C Vernant, & E DeFreitas. (1990). tropical Neuromyelopathies and Retroviruses: A Review. Clinical Infectious Diseases. 12(5). 890–899. 18 indexed citations

14.

Jean-Baptiste, G., et al.. (1990). [Atypical lumbar and nerve-root pain associated with the HTLV-1 virus].. PubMed. 57(12). 869–72. 6 indexed citations

15.

Vernant, J C & Gustavo C. Román. (1989). [Paraplegia associated with HTLV-1 virus].. PubMed. 145(4). 260–6. 2 indexed citations

16.

Vernant, J C, Olivier Gout, G Buisson, et al.. (1988). HTLV-I-Associated tropical spastic paraparesis in martinique: A reappraisal. Annals of Neurology. 23(S1). S133–S135. 19 indexed citations

17.

Gessain, Antoine, Christiane Caudie, Olivier Gout, et al.. (1988). Intrathecal Synthesis of Antibodies to Human T Lymphotropic Virus Type I and the Presence of IgG Oligoclonal Bands in the Cerebrospinal Fluid of Patients with Endemic Tropical Spastic Paraparesis. The Journal of Infectious Diseases. 157(6). 1226–1234. 58 indexed citations

18.

Vernant, J C, Antoine Gessain, Françis Barin, et al.. (1987). Endemic tropical spastic paraparesis associated with human T‐lymphotropic virus type I: A clinical and seroepidemiological study of 25 cases. Annals of Neurology. 21(2). 123–130. 209 indexed citations

19.

Gessain, Antoine, et al.. (1986). Lack of antibody to HTLV-I and HIV in patients with multiple sclerosis from France and French West Indies.. BMJ. 293(6544). 424–425. 29 indexed citations

20.

Gessain, Antoine, J C Vernant, Francis Barin, et al.. (1985). ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS. The Lancet. 326(8452). 407–410. 2385 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact